药物开发 药物开发
Nareh Tahmasian1, Tina Beckett2, Ke Cao2
1University of Toronto, Toronto, ON, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
概括
在阿尔茨海默病 (AD) 模型中,天体细胞转化为神经元可以逆转有害的细胞通信模式. 这种创新方法有望通过重编程脑细胞来恢复认知功能和减少神经炎症.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响全球数百万人,其特点是神经元损失和认知能力下降.
- 目前的研究探索将星球细胞转化为神经元,以取代丢失的脑细胞,并可能治疗AD.
- 初步研究表明,这种天体细胞转化为神经元的转化可以改善AD老鼠模型中的记忆力并减少神经炎症.
研究的目的:
- 调查天体细胞转化为神经元对阿尔茨海默氏病 (AD) 模型海马细胞细胞通信网络的影响.
- 阐明AD中天体细胞转化为神经元的治疗效应的分子机制.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 用于分析人类AD患者和AD大鼠模型中的细胞-细胞通信.
- 病毒介导的重编程转录因子被输送到AD大鼠的海马体,以诱导天体细胞转化为神经元.
- 使用scRNA-seq和空间转录学 (Visium) 来评估转换后细胞通信网络的变化.
主要成果:
- 在人类AD和AD大鼠模型中观察到海马细胞细胞信号的显著变化,包括增加的神经调节素信号.
- 星细胞转化为神经元显著改变了AD大鼠海马中的通信网络.
- 转换过程逆转了许多与AD相关的信号模式,这表明恢复了正常的细胞通信.
结论:
- 星细胞转化为神经元有效地逆转了海马体中关键的AD相关信号通路.
- 这些途径的逆转很可能是认知和神经炎症观察到的改善的原因.
- 这项研究确定了特定的分子途径,这些途径可以在AD治疗中提高治疗效益.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
